Evaluation of the effectiveness of risperidone in the treatment of breath holding spells in children
Iranian Journal of Child Neurology,
Vol. 17 No. 4 (2023),
26 Aban 2023
,
Page 45-54
https://doi.org/10.22037/ijcn.v18i1.40320
Abstract
Objectives
Breath holding spells (BHS) are a type of syncope in children that is commonly seen in the first years of life. Although these attacks do not cause serious damage to the child's brain, in severe or
repeated cases, they expose the brain to hypoxia and cause a lot of stress in parents. In these cases, the clinician should consider therapy. The purpose of this study is to investigate the effectiveness of Risperidone in the treatment of BHS in children visiting the neurology clinic of the Children's Medical Center Hospital.
Materials & Methods
In this randomized clinical trial, the statistical population included patients with the history of Breath Holding spells grades 2 to 3 (after ruling out of seizure disorders) over one year old, visiting the neurology clinic of Tehran Children's Medical Center in 2019. The subjects were randomly selected from patients visiting the clinic using a table of random numbers from the admit ion list. After providing the necessary explanations and obtaining informed consent from their parents, they were treated with low-dose Risperidone (maximum 1 mg) for three months. The patients were observed for three months in terms of frequency and severity of spells monthly.
Results
In this study, the median (25th and 75th percentile) age of subjects was 2.3 (2.0-2.6) years. Both the number and severity of seizures in the subjects had a statistically significant decrease in the period after treatment with Risperidone (P<0.001). The studied boys and girls experienced statistically significant decrease in terms of both the frequency of spells (P-value of 0.002 and 0.039) and intensity of seizures (P=0.016) and P=0.008), respectively after treatment with Risperidone. Also, in the studied children under 2 years old and over 2 years old, both the frequency (P=0.021 and P=0.004) and intensity of spells (P=0.008) 0.016 for subjects under and over 2 years, respectively) had a statistically significant decrease after treatment with risperidone compared to pretreatment.
Conclusion
According to the results of this study, it seems that both the frequency and the intensity of spells in children (regardless of gender and age group), experienced a statistically significant decrease after treatment with Risperidone. We suggest conducting a more comprehensive study considering a larger sample size in order to estimate this issue more correctly.
- Key words: Breath holding spells, grade of BHS, Risperidone, gender, children
How to Cite
References
1. Akalin F, Turan S, Güran T, Ayabakan C, Yilmaz Y. (2017). Increased QT dispersion in breath‐holding spells. Acta Paediatrica, 93(6), 770-774.
2. Mocan H, Yildiran A, Orhan F, Erduran E. (2014). Breath holding spells in 91 children and response to treatment with iron. Archives of disease in childhood, 81(3), 261-262.
3. DiMario FJ. (2015). Prospective study of children with cyanotic and pallid breath-holding spells. Pediatrics, 107(2), 265-269.
4. Kliegman R, Nelson WE. (2011). Nelson text book of pediatrics. 19th ed. Philadelphia, PA: Elsevier/Saunders; p. 2141-5.
5. Wei K, Dorian P, Newman D, Langer A. (2011). Association between QT dispersion and autonomic dysfunction in patients with diabetes mellitus. Journal of the American College of Cardiology, 26(4), 859-863.
6. DiMario FJ. (2018). Breath-holding spells in childhood. American Journal of Diseases of Children, 146(1), 125-131.
7. Leung AK, Leung AA, Wong AH, Hon KL. (2019). Breath-holding spells in pediatrics: a narrative review of the current evidence. Current pediatric reviews, 15(1), 22-29.
8. Buyukgoz C, Mendez MD. (2020). Breath Holding Spells. StatPearls.
9. Bolat N, Eliacik K, Sargin E, Kanik A, Baydan F, Sarioglu B. (2016). Efficacy of a brief psychoeducational intervention for mothers of children with breath-holding spells: a randomized controlled pilot trial. Neuropediatrics, 47(04), 226-232.
10. Hamed SA, Gad EF, Sherif TK. (2018). Iron deficiency and cyanotic breath-holding spells: The effectiveness of iron therapy. Pediatric hematology and oncology, 35(3), 186-195.
11. Gürbüz G, YÜCEL PP, Cokyaman T, Gürbüz ÖB. (2019). Iron supplementation should be given in breath-holding spells regardless of anemia. Turkish journal of medical sciences, 49(1), 230-237.
12. Risperidone plasma concentrations are associated with side effects and effectiveness in children and adolescents with autism spectrum disorder Sanne Maartje Kloosterboer1, 2 | Brenda C.M. de Winter1 | Catrien G. Reichart3 | Mirjam
E.J. Kouijzer4 | Matthias M.J. de Kroon5 | Emma van Daalen6 | Wietske A. Ester3, 7, 8 | Rob Rieken9 | Gwen C. Dieleman2 | Daphne van Altena2 | Beatrijs Bartelds10 | Ron H.N. van Schaik11 | Kazem Nasserinejad12 | Manon H.J. Hillegers2 | Teun van Gelder1 | Bram Dierckx2 | Birgit C.P. Koch
13. Abbaskhanian A, Ehteshami S, Sajjadi S, Rezai MS. (2012). Effects of piracetam on pediatric breath holding spells: A randomized double blind controlled trial. Iran J Child Neurol, 6(4):9-15.
14. Ashrafzadeh F, Rakhshandeh H, Kafie L. (2004). Clinical Efficacy of Piracetam on Breath Holding Spells in Children. Scientific Journal of Hamadan University of Medical Sciences, 11(2), 26-28.
15. Ashrafi MR, Mohammadi M, Shervin-Badve R. (2003). Efficacy of Piracetam in treatment of breath-holding spells. Iranian journal of Pediatrics, 12(4), 33-36.
16. Walsh M, Knilans TK, Anderson JB, Czosek RJ. (2012). Successful treatment of pallid breath-holding spells with fluoxetine. Pediatrics, 130(3):e685-9. doi:peds.2011-1257.
17. Farzadfard SZ, Ashrafzadeh F, Beiraghi Toosi M, Mahrad Majd H, Shahabifar M. (2020). Effect of Fluoxetine Therapy on Breath-Holding Spells in Children: A Clinical Trial Study. International Journal of Pediatrics, 8(1), 10775-10783.
18. Khashabi J. (2002). Breath holding spells: response to treatment with. Iron. Iranian journal of Pediatrics, 12(1), 17-21.
19. Daoud AS, Batieha A, al-Sheyyab M, Abuekteish F, Hijazi SA. Effectiveness of iron therapy on breath-holding spells. J Pediatr. 1997; 130:547-550.
20. Abosdera MM, Sabry MM, Abdel-Moneim ES. Breath holding spells; its relation to iron deficiency anemia, and electroencephalogram findings. Am J Res Commun. 2016; 12:35-45.
21. Bhat MA, Ali W, Mohidin K, Sultana M. Prospective study of severe breath holding spells and role of iron. J Pediatr Neurol. 2007; 5:27-32.
22. Dai AI, Demiryürek AT. Effectiveness oral theophylline, piracetam, and iron treatments in children with simple breath-holding spells. J Child Neurol. 2020; 35: 25-30
23. Ghareib BA, Khalil M, Gaber DM. A comparative study of the efficacy of using piracetam with iron therapy versus iron therapy alone in children with breath-holding spells. Alexandria J Pediatr. 2013; 30:26-31.
24. Gurbuz G, Perk P, Cokyaman T, Gurbuz ÖB. Iron supplementation should be given in breath-holding spells regardless of anemia. Turk J Med Sci. 2019; 49: 230-237.
25. Handan U, Şükrü C, Gülhis D, Hafize G, Atilla EH, Nejat A. Serum soluble transferrin receptor is a valuable diagnostic tool in iron deficiency of breath-holding spells. Pediatr Hematol Oncol. 2005; 22:711-716.
26. Hussain S, Afzal M, Imam SM, Sabir MU, Tarar SH, Asghar I. Breath holding spells: demographic profile and efficacy of iron supplementation in children with breath holding spells and anemia on reduction in frequency of these spells. Pak Armed Forces Med J. 2016; 66(suppl 1):S26-S30.
27. Jain R, Omanakuttan D, Singh A, Jajoo M. Effect of iron supplementation in children with breath holding spells. J Paediatr Child Health. 2017; 53:749-753.
28. Mocan H, Yildiran A, Orhan F, Erduran E. Breath holding spells in 91 children and response to treatment with iron. Arch Dis Child. 1999; 81:261-262.
29. Tonekaboni SH, Alavi S, Mahvelati SF, Tabasi Z. Effects of oral iron supplement on breath-holding spells in children. Iran J Child Neurol. 2006; 1:33-37.
30. Ziaullah SN, Shah S, Talaat A. Iron deficiency anemia as a cause of breath holding spells. System. 2005; 12:13.
- Abstract Viewed: 169 times